治疗过活性膀综合征的米拉贝格朗和抗胆固醇药:一个元分析
Luisa Gracio Ferreira Sartori1, Bruno Monteiro Nunes2, Daniela Farah3,4
1Faculdade de Ciências Medicas da Santa Casa de São Paulo, São Paulo, SP, Brazil.
概括
米拉贝格朗和抗肌糖类药物提供类似的过活性膀治疗疗效和坚持. 米拉贝格伦显示出更好的安全性,副作用较少,包括口腔干燥和胃肠道问题.
科学领域:
- 药理学 药理学是指药理学的学科.
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 临床医学 临床医学
背景情况:
- 过度活跃的膀 (OB) 显著影响生活质量.
- 抗胆固醇药物是一种常见的OB治疗方法,但有副作用.
- 米拉贝格朗为OB管理提供了不同的作用机制.
研究的目的:
- 进行比较mirabegron和抗肌糖药物用于过度活性膀治疗的元分析.
- 为了评估和比较mirabegron和抗糖药之间的疗效,安全性和治疗坚持.
- 综合了关于OB药物治疗的随机对照试验 (RCT) 的证据.
主要方法:
- 在EMBASE,PubMed,Cochrane和LILACS数据库中进行系统的文献搜索,截至2021年9月.
- 包括涉及被诊断患有OB症状的妇女的RCT,将mirabegron与抗肌肉药进行比较.
- 使用RevMan 5.4进行元分析,并使用随机效应模型计算风险比率和平均差异;使用Cochrane协作工具和GRADE评估偏差风险和证据质量.
主要成果:
- 包含10774名患者的14项研究被纳入了元分析.
- 与抗糖药相比,Mirabegron的总不良事件显著减少 (RR 0.93),相比之下,抗糖药的总不良事件显著减少.
- 与mirabegron一起观察到胃肠道疾病 (RR 0.58) 和口腔干燥 (RR 0.44) 的风险较低;在疗效或坚持方面没有显著差异 (RR 0.99).
结论:
- 米拉贝格朗和抗肌肉性药物在过度活跃的膀中表现出相似的疗效和治疗坚持.
- 米拉贝格朗具有良好的安全性,其特点是减少整体和特定不良事件.
- 这些发现支持mirabegron作为治疗过度活跃膀的替代治疗选择,具有更好的耐受性.
相关概念视频
Cholinergic Antagonists: Therapeutic Uses
776
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
776
Cholinergic Antagonists: Pharmacokinetics
516
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
516
Cholinergic Antagonists: Pharmacological Actions
1.2K
Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
1.2K
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
716
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
716
Direct-Acting Cholinergic Agonists: Pharmacological Actions
1.4K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
1.4K
Direct-Acting Cholinergic Agonists: Therapeutic Uses
791
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
791


